Literature DB >> 22798321

Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.

Emily S Charlson1, Joshua M Diamond, Kyle Bittinger, Ayannah S Fitzgerald, Anjana Yadav, Andrew R Haas, Frederic D Bushman, Ronald G Collman.   

Abstract

RATIONALE: Long-term survival after lung transplantation is limited by infectious complications and by bronchiolitis obliterans syndrome (BOS), a form of chronic rejection linked in part to microbial triggers.
OBJECTIVES: To define microbial populations in the respiratory tract of transplant patients comprehensively using unbiased high-density sequencing.
METHODS: Lung was sampled by bronchoalveolar lavage (BAL) and upper respiratory tract by oropharyngeal wash (OW). Bacterial 16S rDNA and fungal internal transcribed spacer sequencing was used to profile organisms present. Outlier analysis plots defining taxa enriched in lung relative to OW were used to identify bacteria enriched in lung against a background of oropharyngeal carryover.
MEASUREMENTS AND MAIN RESULTS: Lung transplant recipients had higher bacterial burden in BAL than control subjects, frequent appearance of dominant organisms, greater distance between communities in BAL and OW indicating more distinct populations, and decreased respiratory tract microbial richness and diversity. Fungal populations were typically dominated by Candida in both sites or by Aspergillus in BAL but not OW. 16S outlier analysis identified lung-enriched taxa indicating bacteria replicating in the lower respiratory tract. In some cases this confirmed respiratory cultures but in others revealed enrichment by anaerobic organisms or mixed outgrowth of upper respiratory flora and provided quantitative data on relative abundances of bacteria found by culture.
CONCLUSIONS: Respiratory tract microbial communities in lung transplant recipients differ in structure and composition from healthy subjects. Outlier analysis can identify specific bacteria replicating in lung. These findings provide novel approaches to address the relationship between microbial communities and transplant outcome and aid in assessing lung infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798321      PMCID: PMC3480531          DOI: 10.1164/rccm.201204-0693OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  45 in total

1.  Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis.

Authors:  J Kirk Harris; Mary Ann De Groote; Scott D Sagel; Edith T Zemanick; Robert Kapsner; Churee Penvari; Heidi Kaess; Robin R Deterding; Frank J Accurso; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

2.  Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14.

Authors:  S M Palmer; W Klimecki; L Yu; N L Reinsmoen; L D Snyder; T M Ganous; L Burch; D A Schwartz
Journal:  Am J Transplant       Date:  2007-01-11       Impact factor: 8.086

3.  Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.

Authors:  Frank D'Ovidio; Marco Mura; Melanie Tsang; Thomas K Waddell; Michael A Hutcheon; Lianne G Singer; Denis Hadjiliadis; Cecilia Chaparro; Carlos Gutierrez; Andrew Pierre; Gail Darling; Mingyao Liu; Shaf Keshavjee
Journal:  J Thorac Cardiovasc Surg       Date:  2005-05       Impact factor: 5.209

4.  Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa.

Authors:  J L Flanagan; E L Brodie; L Weng; S V Lynch; O Garcia; R Brown; P Hugenholtz; T Z DeSantis; G L Andersen; J P Wiener-Kronish; J Bristow
Journal:  J Clin Microbiol       Date:  2007-04-04       Impact factor: 5.948

5.  Innate immunity influences long-term outcomes after human lung transplant.

Authors:  Scott M Palmer; Lauranell H Burch; Anil J Trindade; R Duane Davis; Walter F Herczyk; Nancy L Reinsmoen; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2005-01-07       Impact factor: 21.405

6.  Assessing oropharyngeal dysphagia after lung transplantation: altered swallowing mechanisms and increased morbidity.

Authors:  B Zane Atkins; Melissa S Trachtenberg; Rebecca Prince-Petersen; Gina Vess; Errol L Bush; Keki R Balsara; Shu S Lin; R Duane Davis
Journal:  J Heart Lung Transplant       Date:  2007-11       Impact factor: 10.247

7.  Infections in lung allograft recipients: ganciclovir era.

Authors:  Vincent G Valentine; Ryan W Bonvillain; Meera R Gupta; Gisele A Lombard; Stephanie G LaPlace; Gundeep S Dhillon; Guoshun Wang
Journal:  J Heart Lung Transplant       Date:  2008-03-10       Impact factor: 10.247

8.  Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome.

Authors:  Phil Botha; Lynda Archer; Rachel L Anderson; Jim Lordan; John H Dark; Paul A Corris; Kate Gould; Andrew J Fisher
Journal:  Transplantation       Date:  2008-03-15       Impact factor: 4.939

9.  Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.

Authors:  Janna M Munster; Wim van der Bij; Myrte B Breukink; Gerrit van der Steege; Mike W Zuurman; Bouke G Hepkema; Erik A M Verschuuren; Willem J van Son; Marc A J Seelen
Journal:  Transplantation       Date:  2008-12-27       Impact factor: 4.939

10.  Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities.

Authors:  Catherine A Lozupone; Micah Hamady; Scott T Kelley; Rob Knight
Journal:  Appl Environ Microbiol       Date:  2007-01-12       Impact factor: 4.792

View more
  135 in total

Review 1.  The Microbiome and the Respiratory Tract.

Authors:  Robert P Dickson; John R Erb-Downward; Fernando J Martinez; Gary B Huffnagle
Journal:  Annu Rev Physiol       Date:  2015-11-02       Impact factor: 19.318

2.  Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Bianca Harris; Sejal M Morjaria; Eric R Littmann; Alexander I Geyer; Diane E Stover; Juliet N Barker; Sergio A Giralt; Ying Taur; Eric G Pamer
Journal:  Am J Respir Crit Care Med       Date:  2016-08-15       Impact factor: 21.405

Review 3.  The role of the bacterial microbiome in lung disease.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

4.  Molecular analysis of bacterial contamination on stethoscopes in an intensive care unit.

Authors:  Vincent R Knecht; John E McGinniss; Hari M Shankar; Erik L Clarke; Brendan J Kelly; Ize Imai; Ayannah S Fitzgerald; Kyle Bittinger; Frederic D Bushman; Ronald G Collman
Journal:  Infect Control Hosp Epidemiol       Date:  2018-12-18       Impact factor: 3.254

5.  Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA.

Authors:  Brendan J Kelly; Robert Gross; Kyle Bittinger; Scott Sherrill-Mix; James D Lewis; Ronald G Collman; Frederic D Bushman; Hongzhe Li
Journal:  Bioinformatics       Date:  2015-03-29       Impact factor: 6.937

Review 6.  The human mycobiome.

Authors:  Patrick C Seed
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

7.  Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation.

Authors:  Junpeng Wang; Xin Li; Xiaoqiang Wu; Zhiwei Wang; Chan Zhang; Guanghui Cao; Shun Liu; Tianzhong Yan
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-24       Impact factor: 4.813

Review 8.  Impact of environmental factors on alloimmunity and transplant fate.

Authors:  Leonardo V Riella; Jessamyn Bagley; John Iacomini; Maria-Luisa Alegre
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

9.  Insights from the European Respiratory Society 2018 Annual International Congress in the fields of thoracic surgery and lung transplantation.

Authors:  Rogier A S Hoek; Stelios Gaitanakis; Merel E Hellemons
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

10.  Development of a Stable Lung Microbiome in Healthy Neonatal Mice.

Authors:  Matea Kostric; Katrin Milger; Susanne Krauss-Etschmann; Marion Engel; Gisle Vestergaard; Michael Schloter; Anne Schöler
Journal:  Microb Ecol       Date:  2017-09-13       Impact factor: 4.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.